3 ms·
> we are seeing a resurgence of bacteria resistant to antibiotics, though, and we have no new lines of antibiotics to fight them. These advances may only be tem
by venomsnake 12y ago
> we are seeing a resurgence of bacteria resistant to antibiotics, though, and we have no new lines of antibiotics to fight them. These advances may only be temporary.
We don't develop such, due to the broken way our pharmacy research is done.
It makes no sense for pharma companies to develop antibiotics due to low ROI and lifetime of the product. A better approach for this is government to fund researchers for areas that private sector has abandoned.
- ekianjo 12y ago> A better approach for this is government to fund researchers for areas that private sector has abandoned. yeah, like Ebola research funding done by the government ? That was an efficient model.